CDKN2A Gene Inactivation in Ovarian Cancer
Author Information
Author(s): Niederacher D, Yan H-Y, An H-X, Bender H G, Beckmann M W
Primary Institution: Heinrich-Heine-University
Hypothesis
What is the role of CDKN2A in the development of sporadic ovarian cancer?
Conclusion
The CDKN2A gene is involved in the tumorigenesis of ovarian cancer, but the exact mechanisms of its inactivation remain unclear.
Supporting Evidence
- 65% of the samples showed loss of heterozygosity at 9p21–22.
- Methylation in exon 2 of the CDKN2A gene was found in 26% of the samples.
- Absence of CDKN2A gene expression was shown in 27% at the mRNA level.
Takeaway
Scientists studied a gene called CDKN2A to see how it affects ovarian cancer, and they found that it might play a role in causing the cancer, but they don't know exactly how.
Methodology
The study examined loss of heterozygosity, homozygous deletion, mutation, methylation status, and expression of the CDKN2A gene in serous papillary ovarian cancer.
Limitations
The mechanisms of CDKN2A gene inactivation in serous papillary ovarian cancer remain unclear.
Participant Demographics
Participants had serous papillary ovarian cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website